China Approves First Recombinant Botulinum Toxin for Glabellar Lines
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Tag: Claruvis Pharmaceutical
All
Popular
All
LatestSorry, No Posts Found
All
Latest
Cartessa Aesthetics Launches Onda Pro for Noninvasive Body Contouring in US and Canada
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.
